Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics on the deal. NLS Pharmaceutics completed the direct offering and concurrent private placement transaction with certain...
NLS Pharmaceutics’ $3.2 Million Common Share Offering
PAR Technology’s Acquisition of MENU Technologies
Wenger Vieli advised the shareholders of MENU Technologies Ltd on the deal. MENU has become part of the NYSE listed PAR Technology Corp. group. The MENU...